EFMODY

This brand name is authorized in Croatia, Estonia, Ireland, Israel, Lithuania, Poland, Romania.

Active ingredients

The drug EFMODY contains one active pharmaceutical ingredient (API):

1	Hydrocortisone UNII WI4X0X7BPJ - HYDROCORTISONE
	Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates.
	Read more about Hydrocortisone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H02AB09	Hydrocortisone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1849394, 1849406, 1849417
IL	מִשְׂרַד הַבְּרִיאוּת	9290, 9291
LT	Valstybinė vaistų kontrolės tarnyba	1092746, 1092747, 1092748
PL	Rejestru Produktów Leczniczych	100455200, 100455225, 100455232
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68180001, W68181001, W68182001